A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and CAMP Signaling

Overview

Journal Mol Pharmacol

Specialties Molecular Biology
Pharmacology

Date 2018 Jun 29

PMID 29950405

Citations 16

Authors

Monica Soto-Velasquez

Michael P Hayes

Aktan Alpsoy

Emily C Dykhuizen

Val J Watts

Affiliations

Soon will be listed here.

Abstract

Functional characterization of adenylyl cyclase (AC) isoforms has proven challenging in mammalian cells because of the endogenous expression of multiple AC isoforms and the high background cAMP levels induced by nonselective AC activators. To simplify the characterization of individual transmembrane AC (mAC) isoforms, we generated a human embryonic kidney cell line 293 (HEK293) with low cAMP levels by knocking out two highly expressed ACs, AC3 and AC6, using CRISPR/Cas9 technology. Stable HEK293 cell lines lacking either AC6 (HEK-ACΔ6) or both AC3 and AC6 (HEK-ACΔ3/6) were generated. Knockout was confirmed genetically and by comparing cAMP responses of the knockout cells to the parental cell line. HEK-ACΔ6 and HEK-ACΔ3/6 cells revealed an 85% and 95% reduction in the forskolin-stimulated cAMP response, respectively. Forskolin- and G-coupled receptor-induced activation was examined for the nine recombinant mAC isoforms in the HEK-ACΔ3/6 cells. Forskolin-mediated cAMP accumulation for AC1-6 and AC8 revealed 10- to 250-fold increases over the basal cAMP levels. All nine mAC isoforms, except AC8, also exhibited significantly higher cAMP levels than the control cells after G-coupled receptor activation. Isoform-specific AC regulation by protein kinases and Ca/calmodulin was also recapitulated in the knockout cells. Furthermore, the utility of the HEK-ACΔ3/6 cell line was demonstrated by characterizing the activity of novel AC1 forskolin binding-site mutants. Hence, we have developed a HEK293 cell line deficient of endogenous AC3 and AC6 with low cAMP background levels for studies of cAMP signaling and AC isoform regulation.

Citing Articles

Inhibition of adenylyl cyclase 1 (AC1) and exchange protein directly activated by cAMP (EPAC) restores ATP-sensitive potassium (K) channel activity after chronic opioid exposure.

Klein A, Alam S, Johnson K, Kriner C, Beck B, Nelson B bioRxiv. 2025; .

PMID: 39974972 PMC: 11838493. DOI: 10.1101/2025.02.03.636278.

Germline mutations in a G protein identify signaling cross-talk in T cells.

Ham H, Jing H, Lamborn I, Kober M, Koval A, Berchiche Y Science. 2024; 385(6715):eadd8947.

PMID: 39298586 PMC: 11811912. DOI: 10.1126/science.add8947.

A molecular mechanism to diversify Ca signaling downstream of Gs protein-coupled receptors.

Brands J, Bravo S, Jurgenliemke L, Gratz L, Schihada H, Frechen F Nat Commun. 2024; 15(1):7684.

PMID: 39227390 PMC: 11372221. DOI: 10.1038/s41467-024-51991-6.

KCTD proteins regulate morphine dependence via heterologous sensitization of adenylyl cyclase 1 in mice.

Ding Z, Zhang C, Yang H, Chen J, Sun Z, Zhen X PLoS Biol. 2024; 22(7):e3002716.

PMID: 39008526 PMC: 11271871. DOI: 10.1371/journal.pbio.3002716.

Structure of adenylyl cyclase 5 in complex with Gβγ offers insights into ADCY5-related dyskinesia.

Yen Y, Li Y, Chen C, Klose T, Watts V, Dessauer C Nat Struct Mol Biol. 2024; 31(8):1189-1197.

PMID: 38589608 PMC: 11329361. DOI: 10.1038/s41594-024-01263-0.

References

Eichel K, Von Zastrow M . Subcellular Organization of GPCR Signaling. Trends Pharmacol Sci. 2018; 39(2):200-208. PMC: 5830169. DOI: 10.1016/j.tips.2017.11.009. View

Smith K, Gu C, Fagan K, Hu B, Cooper D . Residence of adenylyl cyclase type 8 in caveolae is necessary but not sufficient for regulation by capacitative Ca(2+) entry. J Biol Chem. 2001; 277(8):6025-31. DOI: 10.1074/jbc.M109615200. View

Cumbay M, Watts V . Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors. J Pharmacol Exp Ther. 2001; 297(3):1201-9. View

Wu G, Lai H, Lin Y, CHU Y, Chern Y . N-glycosylation and residues Asn805 and Asn890 are involved in the functional properties of type VI adenylyl cyclase. J Biol Chem. 2001; 276(38):35450-7. DOI: 10.1074/jbc.M009704200. View

Ostrom R, Insel P . The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol. 2004; 143(2):235-45. PMC: 1575337. DOI: 10.1038/sj.bjp.0705930. View

Katsushika S, Chen L, Kawabe J, Nilakantan R, Halnon N, Homcy C . Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc Natl Acad Sci U S A. 1992; 89(18):8774-8. PMC: 50003. DOI: 10.1073/pnas.89.18.8774. View

Brand C, Hocker H, Gorfe A, Cavasotto C, Dessauer C . Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. J Pharmacol Exp Ther. 2013; 347(2):265-75. PMC: 3807061. DOI: 10.1124/jpet.113.208157. View

Tang W, Krupinski J, GILMAN A . Expression and characterization of calmodulin-activated (type I) adenylylcyclase. J Biol Chem. 1991; 266(13):8595-603. View

Gimpl G, Klein U, Reilander H, Fahrenholz F . Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry. 1995; 34(42):13794-801. DOI: 10.1021/bi00042a010. View

10.

Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden T . Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012; 13:134. PMC: 3412702. DOI: 10.1186/1471-2105-13-134. View

11.

Ran F, Hsu P, Wright J, Agarwala V, Scott D, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8(11):2281-2308. PMC: 3969860. DOI: 10.1038/nprot.2013.143. View

12.

Fagan K, Mahey R, Cooper D . Functional co-localization of transfected Ca(2+)-stimulable adenylyl cyclases with capacitative Ca2+ entry sites. J Biol Chem. 1996; 271(21):12438-44. DOI: 10.1074/jbc.271.21.12438. View

13.

Brust T, Alongkronrusmee D, Soto-Velasquez M, Baldwin T, Ye Z, Dai M . Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci Signal. 2017; 10(467). PMC: 5734633. DOI: 10.1126/scisignal.aah5381. View

14.

Sadana R, Dessauer C . Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals. 2008; 17(1):5-22. PMC: 2790773. DOI: 10.1159/000166277. View

15.

Simonds W . G protein regulation of adenylate cyclase. Trends Pharmacol Sci. 1999; 20(2):66-73. DOI: 10.1016/s0165-6147(99)01307-3. View

16.

Bandaranayake A, Almo S . Recent advances in mammalian protein production. FEBS Lett. 2013; 588(2):253-60. PMC: 3924552. DOI: 10.1016/j.febslet.2013.11.035. View

17.

Pierre S, Eschenhagen T, Geisslinger G, Scholich K . Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov. 2009; 8(4):321-35. DOI: 10.1038/nrd2827. View

18.

Andressen K, Norum J, Levy F, Krobert K . Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression. Mol Pharmacol. 2005; 69(1):207-15. DOI: 10.1124/mol.105.015396. View

19.

Alewijnse A, Smit M, Rodriguez Pena M, Verzijl D, Timmerman H, Leurs R . Modulation of forskolin-mediated adenylyl cyclase activation by constitutively active G(S)-coupled receptors. FEBS Lett. 1998; 419(2-3):171-4. DOI: 10.1016/s0014-5793(97)01440-3. View

20.

Mann L, Heldman E, Bersudsky Y, Vatner S, Ishikawa Y, Almog O . Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Bipolar Disord. 2009; 11(8):885-96. DOI: 10.1111/j.1399-5618.2009.00762.x. View